Two Sigma Investments
BNGO icon

Two Sigma Investments’s Bionano Genomics BNGO Stock Holding History

Two Sigma Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,513
Closed -$62K – 4599
2025
Q4 		$62K Buy
+40,513
New +$70.1K ﹤0.01% 3912
2025
Q1 		– Sell
-225
Closed -$3.89K – 3218
2024
Q4 		$3.89K Sell
225
-170
-43% -$2.91K ﹤0.01% 3155
2024
Q3 		$10.7K Buy
+395
New +$12.3K ﹤0.01% 3047
2024
Q1 		– Sell
-6,790
Closed -$770K – 3043
2023
Q4 		$770K Buy
+6,790
New +$709K ﹤0.01% 2226
2022
Q4 		– Sell
-632
Closed -$694K – 2812
2022
Q3 		$694K Sell
632
-539
-46% -$712K ﹤0.01% 1627
2022
Q2 		$970K Buy
1,171
+994
+562% +$1.02M ﹤0.01% 1559
2022
Q1 		$274K Buy
+177
New +$239K ﹤0.01% 2242
2021
Q3 		– Sell
-626
Closed -$2.75M – 4244
2021
Q2 		$2.75M Sell
626
-151
-19% -$596K 0.01% 1612
2021
Q1 		$3.77M Buy
+777
New +$4.38M 0.01% 1246
2020
Q1 		– Sell
-96
Closed -$71K – 3131
2019
Q4 		$71K Buy
+96
New +$56.1K ﹤0.01% 3546

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Investments's BNGO Position: Q1 2026 in Review

Two Sigma Investments sold out of Bionano Genomics (BNGO) in Q1 2026, closing a stake of 40,513 shares — an estimated $62K sold.

Two Sigma Investments first reported a position in BNGO in Q4 2019 and held it in 10 quarters. The position peaked at $3.77M in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Two Sigma Investments reported no remaining Bionano Genomics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 40,513 Bionano Genomics shares in Q1 2026, an estimated $62K.
  • Two Sigma Investments first reported a position in Bionano Genomics in Q4 2019 and held it in 10 quarters.
  • Two Sigma Investments's Bionano Genomics position peaked at $3.77M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.